首页> 外文期刊>Medical oncology >Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population.
【24h】

Association of LAPTM4B gene polymorphism with nasopharyngeal carcinoma susceptibility in a Chinese population.

机译:LAPTM4B基因多态性与中国人群鼻咽癌易感性的关系。

获取原文
获取原文并翻译 | 示例
           

摘要

Lysosome-associated protein transmembrane-4 beta (LAPTM4B) is a novel cancer-related gene. It has two alleles designated LAPTM4B 1 and LAPTM4B 2. Previous studies have revealed that LAPTM4B polymorphisms contribute to the risk of many cancers. The aim of this study was to investigate the association between different LAPTM4B alleles and the risk of nasopharyngeal carcinoma (NPC), one of the most common cancers in southern China. Using polymerase chain reaction (PCR) in a case-control study, we detected the LAPTM4B genotype in peripheral blood samples from 134 patients with NPC and 327 control subjects. The chi-square test was used to analyze differences of categorical variables and Hardy-Weinberg equilibrium. Odds ratios and 95 % CI were computed using an unconditional logistic regression model. The frequency of allele 2 was 26.87 % in the NPC group, which was not significantly different from that of the control group (27.98 %, P = 0.867). Using the LAPTM4B 1/1 genotype as a reference, we found that the 1/2, 2/2 and 1/2 + 2/2 genotype were also not associated with the risk of NPC. No association was observed between LAPTM4B gene polymorphisms and the risk of NPC adjusted by gender and age. The results of our study indicated that the polymorphism of LAPTM4B gene did not influence the susceptibility of NPC in the Chinese population. Large-scale studies are needed to confirm our findings.
机译:溶酶体相关蛋白跨膜4β(LAPTM4B)是一个新的癌症相关基因。它有两个等位基因,分别命名为LAPTM4B 1和LAPTM4B2。先前的研究表明,LAPTM4B多态性会导致许多癌症的风险。这项研究的目的是调查不同的LAPTM4B等位基因与鼻咽癌(NPC)的风险之间的关联,鼻咽癌是中国南方最常见的癌症之一。在病例对照研究中使用聚合酶链反应(PCR),我们在134名NPC患者和327名对照受试者的外周血样本中检测到LAPTM4B基因型。卡方检验用于分析分类变量和Hardy-Weinberg平衡的差异。使用无条件逻辑回归模型计算赔率和95%CI。 NPC组等位基因2的频率为26.87%,与对照组无显着性差异(27.98%,P = 0.867)。使用LAPTM4B 1/1基因型作为参考,我们发现1 / 2、2 / 2和1/2 + 2/2基因型也与NPC风险无关。 LAPTM4B基因多态性与按性别和年龄调整的NPC风险之间未发现关联。我们的研究结果表明,LAPTM4B基因的多态性不影响中国人群中鼻咽癌的易感性。需要进行大规模研究以证实我们的发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号